United States: Can the Third Circuit's Decision In In Re Lipitor Antitrust Litigation Be Used As An Appellate Forum-Shopping Tool In Antitrust Cases?

Last Updated: May 9 2017
Article by Kristina Caggiano Kelly

On April 13, 2017, the Third Circuit issued an eagerly awaited precedential opinion in In re Lipitor Antitrust Litigation, No. 14-4202. The case represented several consolidated appeals involving two different classes of plaintiffs and three different jurisdictional questions. One of those jurisdictional questions turned on a peculiar nuance in the structure of the complaint, which resulted in a question of patent law (typically the exclusive province of the Federal Circuit) falling within the appellate jurisdiction of the regional circuit.

Among the issues presented were the plaintiffs' allegations that the branded drug companies holding the patents for Lipitor and Effexor XR engaged in an overarching monopolistic scheme to delay generic entry into the market. The scheme allegedly included fraudulently procuring and enforcing the underlying patents, and entering into a reverse-payment settlement agreement with a generic manufacturer.

The district judge dismissed most of the plaintiffs' claims. Plaintiffs appealed to the Third Circuit, but defendants argued that the appeal should be transferred to the Court of Appeals for the Federal Circuit. The Federal Circuit has exclusive jurisdiction over appeals from civil actions "arising under" patent law, per 28 U.S.C. 1295(a)(1). Not all cases presenting questions of patent law, however, necessarily arise under patent law. The Third Circuit found that this was one of those cases.

In its 2013 decision FTC v. Actavis, the Supreme Court held that the terms common to many reverse payment settlements violate antitrust laws. Importantly for the present case, the Court there also found that it is normally not necessary to litigate patent validity in order to resolve the antitrust issue. Because the antitrust issue is separable from any underlying patent issues, a claim that is limited to the antitrust issue will not invoke Federal Circuit jurisdiction.

In In re Lipitor Antitrust Litigation, the plaintiffs' monopolization claims encompassed the totality of the patent holder's allegedly anticompetitive conduct, of which patent enforcement was only one component. Other components included fraudulent procurement of a patent and entering into a reverse-payment settlement agreement. Because infringement and validity of the underlying patent spoke only to one theory underlying the claim (whether the behavior should be considered anticompetitive where the defendant's patent was valid and infringed)—rather than the claim itself—the monopolization claim did not "arise under" patent law.

One could easily envision, however, the plaintiffs here making a different choice and structuring their complaint so that it had alleged at least one claim directly implicating the validity or infringement of the subject patents, thus ensuring that the Federal Circuit, and not the regional circuit, would have exclusive jurisdiction over the entire appeal.

The Third Circuit's holding thus raises the possibility that a plaintiff could intentionally structure an antitrust claim to invoke or avoid Federal Circuit jurisdiction in a case like this. The universe of cases where such a strategy could be employed is significant for two reasons:

First, substantive patent litigation is likely only one part of any large company's overall competitive strategy. Strategic patent procurement and enforcement, trade secret policies, marketing, erecting barriers to competitor entry through pricing, supply-side economics, and entering exclusive licenses and contracts, are among the weapons in a large company's market domination arsenal. By structuring an antitrust, monopolization, or unfair competition claim to encompass all of a company's allegedly anticompetitive activity, of which a substantive patent argument is only one underlying theory, a plaintiff might secure regional circuit appellate jurisdiction.

Second, such strategic claiming would be particularly relevant where the underlying patent claim arose in the Hatch-Waxman context, because reverse-payment settlements are often inevitable in such cases. Understanding why such settlement structures are often unavoidable requires understanding one of the main arguments against the FTC's position in Actavis: The Hatch-Waxman Act creates a reverse leverage situation between a plaintiff and defendant that is not often found in any other area of law.

Under normal circumstances, a patent infringement action is filed after a defendant has made, used, or sold a patented product and profited from that act. The amount of money that the defendant should have paid for a license, or the lost sales implicated by the defendant's actions define the scope of the defendant's damages exposure. A settlement between the parties typically reflects the defendant paying to the plaintiff a portion of that damages exposure in order to escape liability, perhaps mitigated by the parties' perception of the likely outcome. Where the defendant has a seemingly persuasive case that the asserted patent is invalid, one might expect the settlement payment to be smaller, reflecting the plaintiff patent holder's increased eagerness to settle the case and avoid losing its patent protection.

Because the Hatch-Waxman Act creates a statutory cause of action for infringement where no actual infringement or damages has taken place, the typical settlement calculus does not apply. There is no damages exposure, and thus no amount that the defendant would be willing to pay to the plaintiff to escape liability. It is this unique shift in the balance of leverage between the plaintiff and the defendant that created the reverse-payment settlement in the first place. Where the damages exposure is set at zero, a wary plaintiff's typical offer to discount the damages amount thus results in a negative number, i.e., plaintiff ends up paying the defendant to respect the patent.

The Supreme Court in Actavis was not convinced that reverse-payment settlements are simply the innocent reflection of the unique and artificial environment in which Hatch-Waxman litigants must negotiate settlement agreements. The Actavis Court observed that large "unexplained" reverse-payment settlement agreements indicated that branded drug companies were habitually paying off generics in order to continue enforcing invalid patents. Even without determining the validity of the underlying patent, the Court concluded that the terms of many reverse-payment settlements were anticompetitive in nature.

By concluding that reverse-payment settlement agreements can be found to be anticompetitive without determining the merits of the underlying patent infringement and invalidity claims, the Supreme Court confirmed that entering (or attempting to enter) a reverse payment settlement creates a cause of action out of a patent litigation that does not "arise under" patent laws for jurisdictional purposes.

Thus, after Actavis and In re Lipitor, anytime a reverse settlement shows up in the history of a litigated patent, a savvy plaintiff may be able to use that historical fact to support an antitrust claim that incidentally resolves the validity of the patent without being appealable to the Federal Circuit.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions